Aktis Oncology, Inc. AKTS
16.15 USD -0.25 (-1.52%)
Regular-session close
16.15 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
16.00 Day range 16.74
14.59 52-week range 32.23
- YTD
- -27.90%
- 1 year
- -27.90%
AKTS revenue history
Revenue is income from the company’s ordinary business activities.
6,497,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 6,497,000 | 5,010,000 | 336.92% |
| FY 2024 | 2024-12-31 | 1,487,000 | 1,487,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:00.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
